Categories: aggregated

Meet Cannabizetol: Why We’re Still Discovering New Cannabis Molecules in 2025

The compound is called cannabizetol (CBGD), and it’s only the fourth dimeric cannabinoid ever identified in cannabis. When researchers tested it against 84 different inflammatory genes, it showed significantly higher anti-inflammatory activity than any previously studied dimeric cannabinoid. It works through the NF-κB pathway—essentially a master switch for inflammation throughout the human body—and exhibits powerful antioxidant properties that could have applications in dermatology, chronic inflammation, and potentially dozens of other medical conditions we haven’t even imagined yet.

Jason

Share
Published by
Jason

Recent Posts

A Beginner’s Guide to Low-Dose Social Drinking

Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…

8 hours ago

6 Surprising Truths Cannabis Actually Teaches You About Yourself

A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…

1 day ago

DEA Hearing Bombshell: Marijuana Rescheduling Rules Never Existed

Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…

2 days ago

Why Trump Lost the 2026 Midterms: The 2028 Cannabis & Hemp Playbook

Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…

3 days ago

Dr. Siegel’s Marijuana Math Doesn’t Add Up: Why the Data on Parents, Teens, and Cannabis Tells a Different Story

On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…

5 days ago

The Truth About Medical Marijuana: Why Cannabis Is Neither a Miracle Nor a Menace

Is cannabis a miracle cure or a gateway to ruin? We break down the latest…

6 days ago